Clinical Features and Electroencephalogram Analysis of Brain Network Functional Connectivity in Anti-Leucine-Rich Glioma-Inactivated 1 Antibody Encephalitis
Xiaosu Guo,Huimin Shi,Yuteng Sun,Yuan Xing,Xin Guo,Zhiyuan Shen,Mengyi Zheng,Yaxin Zhang,Yicun Jia,Ye Li,Junqiang Bao,Shujuan Tian
DOI: https://doi.org/10.2147/jir.s485190
IF: 4.5
2024-10-29
Journal of Inflammation Research
Abstract:Xiaosu Guo, 1– 4, &ast Huimin Shi, 1, 2, &ast Yuteng Sun, 1 Yuan Xing, 1– 3 Xin Guo, 1– 3 Zhiyuan Shen, 1– 3 Mengyi Zheng, 1 Yaxin Zhang, 1 Yicun Jia, 1 Ye Li, 1 Junqiang Bao, 1, 2 Shujuan Tian 1– 3 1 Department of Neurology, The First Hospital of Hebei Medical University, Shijiazhuang, Hebei, People's Republic of China; 2 Department of Neurology, Hebei Hospital, Xuanwu Hospital, Capital Medical University, Shijiazhuang, Hebei, People's Republic of China; 3 Neuromedical Technology Innovation Center of Hebei Province, Shijiazhuang, Hebei, People's Republic of China; 4 Brain Aging and Cognitive Neuroscience Laboratory of Hebei Province, Shijiazhuang, People's Republic of China &astThese authors contributed equally to this work Correspondence: Shujuan Tian; Junqiang Bao, Department of Neurology, The First hospital of Hebei Medical University, Shijiazhuang, Hebei, 050030, People's Republic of China, Tel +86-0311-87156309, Email ; Purpose: To summarize the clinical manifestations, laboratory findings, and magnetic resonance imaging (MRI) characteristics of anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis (anti-LGI1 antibody encephalitis) and explore the electroencephalogram (EEG) features. Patients and Methods: We retrospectively analyzed the medical history of 16 patients diagnosed with anti-LGI1 antibody encephalitis at the First Hospital of Hebei Medical University from 2021 to 2023. EEGs of patients with anti-LGI1 antibody encephalitis and healthy individuals were analyzed. Based on Video-EEG signal analysis of EEG δ, θ, α, β frequency bands, weighted phase lag index values were calculated to form brain network matrices, studying differences in coherence between brain regions of patients with anti-LGI1 antibody encephalitis and healthy individuals. Results: Patients with anti-LGI1 antibody encephalitis often presented with subacute onset seizures and cognitive decline. Routine test of cerebrospinal fluid was mostly normal. Serum testing revealed hyponatremia in 62.50% of patients, along with positive serum antinuclear antibodies, decreased vitamin B12, and abnormal cytokines such as interleukin-6. Head MRI revealed abnormal lesions related to the disease in seven cases (43.75%), mainly located in the unilateral or bilateral frontal and temporal lobes of the hippocampus. The EEG mainly showed generalized and focal slow waves, sometimes with focal discharges. Brain network functional connectivity analysis found a significant weakening of functional connections in the frontal-temporal lobe in the δ and β frequency bands. Intravenous pulse corticosteroids and intravenous immunoglobulin are first-line immunotherapies for anti-LGI1 antibody-related encephalitis. The disease recovery and cognitive decline improved in most patients. Conclusion: Anti-LGI1 antibody encephalitis is characterized by seizures and cognitive dysfunction. Serum may show abnormalities in immune indicators such as cytokines. Head MRI mainly reveals abnormal signals in the frontal-temporal lobes and the hippocampus. EEG brain network connectivity analysis reveals characteristic weakening of functional connections in the frontal-temporal lobe in the δ and β frequency bands. Keywords: anti-LGI1 antibody encephalitis, epilepsy, electroencephalogram, brain network functional connectivity, immunotherapy Anti-leucine-rich glioma-inactivated 1 (LGI1) antibody encephalitis is an autoimmune disease mediated by anti-LGI1 antibodies. In 2010, Irani et al 1 first identified a group of target antigens of non-neoplastic autoimmune encephalitis, mainly manifested by limbic system involvement, as the LGI1 protein, which opened the prelude to the study of this type of encephalitis. Anti- LGI1 antibody encephalitis is one of the most common borderline encephalitis, and its main clinical manifestations include Facio brachial dystonic seizure (FBDS), other forms of epilepsy, decreased proximal memory, psychobehavioral abnormalities, sleep disorders, and hyponatremia. 2 Unlike anti-NMDA receptor encephalitis which is associated with tumors, anti-LGI1 antibody encephalitis is rarely associated with tumors. 3,4 In this study, the clinical manifestations, laboratory tests, imaging, electroencephalogram (EEG) features, immunotherapy, and prognosis of patients with anti-LGI1 antibody encephalitis were retrospectively analyzed with an aim to assist in the early diagnosis and treatment of the disease. Sixteen patients with autoimmune encephalitis who were diagnosed with anti-LGI1 antibody positivity at the First Hospita -Abstract Truncated-
immunology